financetom
Business
financetom
/
Business
/
Teledyne's fourth-quarter profit beats on robust defense demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Teledyne's fourth-quarter profit beats on robust defense demand
Jan 22, 2025 5:35 AM

Jan 22 (Reuters) - U.S. defense firm Teledyne ( TDY )

reported a fourth-quarter profit on Wednesday that beat

analysts' estimates on the back of robust demand for its target

detection sensors and marine equipment.

On an adjusted basis, the company earned $5.52 per share in

the quarter, compared with the average analyst estimate of

$5.22, according to data compiled by LSEG.

Defense firms have benefited from an uptick in spending amid

the ongoing conflict in the Middle East and the Russia-Ukraine

war.

Revenue from Teledyne's ( TDY ) digital imaging business - that

produces threat detection sensors and cameras for military

applications - rose 2.5% to $822 million in the fourth quarter.

The company reported net sales of $1.5 billion, compared

with $1.42 billion a year earlier.

Teledyne ( TDY ) said it expects 2025 adjusted profit per share

between $21.10 and $21.50. Analysts had expected $21.55.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Omineca Lode Gold Provides Wingdam Exploration Program Update
Omineca Lode Gold Provides Wingdam Exploration Program Update
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Omineca Mining and Metals ( OMMSF ) on Friday said road access and first drill pads have been completed and diamond drilling is underway at the Wingdam hard rock exploration project located in the Cariboo Mining District of south central British Columbia. The company plans a 10-hole. 4,000-meter, program in downstream of the...
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Friday new data from phase 2a trial of imdusiran followed by Barinthus Biotherapeutics' ( BRNS ) VTP-300 plus a low dose of nivolumab in chronic hepatitis B patients showed promising results. The preliminary data showed that trial participants who received the regimen experienced increased rates of HBsAg...
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- Barinthus Biotherapeutics ( BRNS ) on Friday reported encouraging results from its ongoing phase 2b HBV003 trial for chronic hepatitis B. The study, involving 121 participants, assessed VTP-300 in combination with a low dose of anti-PD1 antibody nivolumab, and new data shows eight participants achieved complete HBsAg loss, while two met the criteria...
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- (Updates with General Motors' ( GM ) comment in the second paragraph.) General Motors ( GM ) is planning to cut around 1,000 salaried positions globally in an attempt to streamline its operations, Bloomberg reported Friday, citing people familiar with the matter. In order to win in this competitive market, we need to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved